VG S&P S-Cp 600 Grw

Zacks Research Raises Sterling Infrastructure's Rating to 'Strong Buy'

SiTime insider sells stock

OMERS REDUCED ITS HOLDING IN STERLING INFRASTRUCTURE

Corcept Therapeutics Inc Executives Sean Maduck Sold $1.6 Million in Stocks

SiTime CEO Rajesh Vashist Reports Sale of Company Common Stock

SiTime is said in talks to acquire Renesas’s timing division

Mirion Technologies Completes Acquisition of Paragon Energy Solutions

Boston Partners Reduces Holdings in Sterling Infrastructure

MegaChips Corp Sells SITIME Shares to Book 1.5 Billion Yen Special Gain

InterDigital Director Sells Common Stock

Sterling Infrastructure Announces $400 Million Stock Buyback Program

Federated Signal expects sales of $2.12 billion to $2.16 billion for fiscal 2023

Federated Signal Completes Acquisition of NewWay Truck Company

SiTime Corporation Official Disposes of Company Common Stock

William Blair Maintains Buy Rating on Sterling Infrastructure

SiTime Corp's VP Sells Shares to Cover Option Exercise Costs and/or Tax Obligations

SiTime Corp CFO Elizabeth Howe Sells Stock

William Blair Analyst Maintains Buy Rating on InterDigital

Mirion Technologies Inc. Director Sells Common Stock

MegaChips Disposes of SiTime Corporation Common Stock

SEVEN HILLS RLTY TR COM USD0.001 (S/R 04/12/2025)

SMX Security Matters

Polyrizon

Picard Medical

Synchronoss Tech

PharmaCyte Biotech

Q/C Tech

Rich Sparkle

Tradr 2X Long ASTS Daily ETF

Able View Global

STRL

Zacks Research upgraded Sterling Infrastructure (NASDAQ:STRL) from a "hold" to a "strong-buy" rating. Other analysts have also issued positive ratings, with DA Davidson raising the price target to $460. Sterling Infrastructure's stock performance shows a 52-week range of $96.34 to $419.14, and the company has initiated a $400 million share repurchase program. Institutional investors have significantly increased their stakes in the company.

Market Beat

Sterling Infrastructure

Sterling Infrastructure (NASDAQ:STRL) Upgraded by Zacks Research to "Strong-Buy" Rating

J.P. Morgan analyst Tomohiko Sano maintains a Buy rating on Mirion Technologies due to strategic growth and innovation. The acquisition of Paragon enhances market share in the U.S. and Europe. Investments in AI and digital innovation, along with a strong medical segment, support long-term growth and margin stability. Northland Securities also maintains a Buy rating with a $29.00 price target.

Tip Ranks

Mirion Tech

Strategic Growth and Innovation Drive Buy Rating for Mirion Technologies

Russell Investments Group Ltd. increased its holdings in Dycom Industries by 16.5% in Q2. Analysts have given Dycom a consensus 'Buy' rating, with a target price of $371.25. Dycom's stock opened at $354.84, with a 52-week high of $364.40. The company reported strong quarterly earnings, beating estimates with $3.63 EPS and $1.45 billion revenue, up 14.2% year-over-year.

Russell Investments Group Ltd.

Dycom Industries

Russell Investments Group Ltd. Increases Stock Holdings in Dycom Industries, Inc. $DY

IDCC

InterDigital Inc. has declared a quarterly cash dividend of $0.70 per share on its common stock.

Reuters

InterDigital Comm

InterDigital Inc. declares $0.70 per share quarterly cash dividend

Mirion Technologies director Lawrence D. Kingsley sold 300,000 shares, raising concerns about insider sentiment and future growth plans. Despite this, Mirion's growth catalysts remain unchanged, with a focus on nuclear and medical radiation safety. The sale contrasts with previous share buybacks, highlighting capital allocation challenges. Mirion projects $1.1 billion revenue and $105.2 million earnings by 2028, requiring 7.9% yearly growth. Fair value estimates vary widely, reflecting differing views on acquisition risks and growth potential.

Simplywall

Did a Major Insider Share Sale Just Shift Mirion Technologies' (MIR) Investment Narrative?

SITM

SiTime insider Fariborz Assaderaghi sold 1,500 shares at $291.58 each, totaling $437,370. Post-sale, Assaderaghi owns 84,815 shares, a 1.74% decrease. The transaction was disclosed to the SEC. SiTime's stock rose 12.5%, with a market cap of $9.04 billion. Analysts rate the stock as a "Moderate Buy" with a $332.14 target price. Hedge funds have increased their positions in SiTime.

Sitime

SiTime (NASDAQ:SITM) Insider Fariborz Assaderaghi Sells 1,500 Shares

OMERS ADMINISTRATION Corp reduced its stake in Sterling Infrastructure, Inc. by 32.6% in Q2, owning 9,522 shares worth $2,197,000. Other investors like Millennium Management LLC and Vanguard Group Inc. adjusted their holdings significantly. Analysts have mixed ratings on STRL, with a consensus of 'Moderate Buy' and a price target of $460.00. Sterling Infrastructure's stock opened at $327.78, with a market cap of $10.07 billion. The company announced a $400 million share repurchase plan, indicating potential undervaluation.

OMERS ADMINISTRATION Corp Lowers Stake in Sterling Infrastructure, Inc. $STRL

CORT

Corcept Therapeutics Insider Sold Shares Worth $1,590,490, According to a Recent SEC Filing

marketscreener

Corcept Therap

Corcept Therapeutics Insider Sold Shares Worth $1,590,490, According to a Recent SEC Filing

Officer Sean Maduck of Corcept Therapeutics Inc sold 20,000 shares worth $1.6 million, as disclosed in a Form 4 filed with the SEC. The sale was part of a prearranged trading plan (10b5-1). Ending holdings are 117,896 shares. The Washington Service offers insider trading analysis and data services.

Officer Maduck Sells 20,000 ($1.6M) Of Corcept Therapeutics Inc [CORT]

Officer Lyon Joseph Douglas of Corcept Therapeutics Inc sold 5,000 shares for $397,632 as part of a prearranged trading plan. The transaction was disclosed in a Form 4 filed with the SEC. The officer also exercised options and surrendered shares to cover costs and tax liabilities, ending with 10,523 shares directly held.

Officer Lyon Sells 5,000 ($397.6K) Of Corcept Therapeutics Inc [CORT]

Corcept Therapeutics Inc's CFO, Mokari Atabak, surrendered 118 shares back to the company on December 2, 2025, to cover option exercise costs and tax liabilities. The shares were valued at $9,414, with a price of $79.78 per share. Mokari's direct holdings now total 14,559 shares.

CFO Mokari Surrenders 118 Of Corcept Therapeutics Inc [CORT]

Guyer William Officer of Corcept Therapeutics Inc [CORT] filed a Form 4/A on December 3, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:DateTransactionSharesPriceValue11/17/25Gift5,287$0.00N/A11/25/25Sale4,500$80.90$364,070Ending Holdings: 787 (0 - Direct, 787 - Indirect) For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Officer Guyer Sells 4,500 ($364.1K) Of Corcept Therapeutics Inc [CORT]-Amended

Robb Gary Charles, an officer of Corcept Therapeutics Inc, surrendered 148 shares back to the company to cover option exercise costs and tax liabilities. The transaction was filed with the SEC on December 3, 2025, with the shares valued at $11,807. His ending holdings are 37,052 shares, split between direct and indirect ownership.

Officer Robb Surrenders 148 Of Corcept Therapeutics Inc [CORT]

Joseph K. Belanoff, CEO of Corcept Therapeutics, reported the disposal of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system. This information is for informational purposes only and not financial advice.

Corcept Therapeutics CEO Joseph K. Belanoff Reports Disposal of Common Shares

SOXL

SiTime is in talks to acquire Renesas Electronics' timing components unit, potentially marking its largest acquisition. Renesas is exploring the sale of its timing division, valued at $2 billion, as part of a strategic shift to focus on microcontrollers and power semiconductors. SiTime aims to expand its timing product offerings and capture a larger market share. The deal highlights the importance of timing solutions in AI data centers and other sectors. However, the outcome of the talks remains uncertain, with other contenders possibly emerging.

EE Times

Direxion Semicon Bull 3X

SiTime Exploring Renesas’ $2 Billion Timing Exit